Harmony Biosciences Holdings Inc. (HRMY): Price and Financial Metrics
HRMY Price/Volume Stats
| Current price | $34.28 | 52-week high | $41.61 |
| Prev. close | $33.89 | 52-week low | $28.14 |
| Day low | $33.48 | Volume | 2,976,500 |
| Day high | $34.97 | Avg. volume | 487,867 |
| 50-day MA | $34.22 | Dividend yield | N/A |
| 200-day MA | $33.08 | Market Cap | 1.96B |
HRMY Stock Price Chart Interactive Chart >
Harmony Biosciences Holdings Inc. (HRMY) Company Bio
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders. Its product WAKIX is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded on July 25, 2017 and is headquartered in Plymouth Meeting, PA.
HRMY Price Returns
| 1-mo | 3.16% |
| 3-mo | -12.75% |
| 6-mo | 13.89% |
| 1-year | 6.66% |
| 3-year | -19.61% |
| 5-year | N/A |
| YTD | 6.13% |
| 2023 | -41.38% |
| 2022 | 29.22% |
| 2021 | 17.95% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...